TOP TEN perturbations for 1552296_at (Homo sapiens)

Organism: Homo sapiens
Gene: 1552296_at
Selected probe(set): 1552296_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 1552296_at (1552296_at) across 6672 perturbations tested by GENEVESTIGATOR:

colorectal adenoma study 7 (colonic mucosa) / normal colon mucosa sample

Relative Expression (log2-ratio):-4.642908
Number of Samples:5 / 5
Experimental colorectal adenoma study 7 (colonic mucosa)
Colonic mucosa samples obtained by laser capture microdissection (LCM) from patients with colorectal adenoma.
Control normal colon mucosa sample
Histopathological normal colon mucosa sample obtained by laser capture microdissection (LCM) from the distant normal colon of patients with colorectal cancer.

colorectal cancer study 33 (carcinoma; colonic crypt) / normal colonic crypt epithelial cell sample

Relative Expression (log2-ratio):-4.4960785
Number of Samples:5 / 5
Experimental colorectal cancer study 33 (carcinoma; colonic crypt)
Colonic crypt epithelial cell samples obtained by laser capture microdissection (LCM) from patients with colorectal carcinoma.
Control normal colonic crypt epithelial cell sample
Histopathological normal colonic crypt epithelial cells obtained by laser capture microdissection (LCM) from the distant normal colon of patients with colorectal cancer.

colorectal adenoma study 7 (colonic crypt) / normal colonic crypt epithelial cell sample

Relative Expression (log2-ratio):-4.454178
Number of Samples:5 / 5
Experimental colorectal adenoma study 7 (colonic crypt)
Colonic crypt epithelial cell samples obtained by laser capture microdissection (LCM) from patients with colorectal adenoma.
Control normal colonic crypt epithelial cell sample
Histopathological normal colonic crypt epithelial cells obtained by laser capture microdissection (LCM) from the distant normal colon of patients with colorectal cancer.

colorectal cancer study 9 (recurring) / adjacent colon tissue (recurring)

Relative Expression (log2-ratio):-4.3839846
Number of Samples:4 / 4
Experimental colorectal cancer study 9 (recurring)
LCM-tumor tissue samples of patients who received resection after diagnosis of primary colorectal cancer. Patients developed metastatic recurrence during follow-up after surgery.
Control adjacent colon tissue (recurring)
Histologically normal colon tissue samples from patients with primary colorectal cancer collected after resection. Tissue was further extracted using laser-capture microdissection (LCM). With metastatic recurrence after resection during follow-up.

colorectal cancer study 33 (carcinoma; colonic mucosa) / normal colon mucosa sample

Relative Expression (log2-ratio):-4.331519
Number of Samples:5 / 5
Experimental colorectal cancer study 33 (carcinoma; colonic mucosa)
Colonic mucosa samples obtained by laser capture microdissection (LCM) from patients with colorectal carcinoma.
Control normal colon mucosa sample
Histopathological normal colon mucosa sample obtained by laser capture microdissection (LCM) from the distant normal colon of patients with colorectal cancer.

colorectal cancer study 4 (non-recurring) / adjacent colon tissue (non-recurring)

Relative Expression (log2-ratio):-4.3148394
Number of Samples:76 / 18
Experimental colorectal cancer study 4 (non-recurring)
LCM-tumor tissue samples of patients who received resection after diagnosis of primary colorectal cancer. Patients did not develop metastatic recurrence during follow-up after surgery.
Control adjacent colon tissue (non-recurring)
Histologically normal colon tissue samples from patients with primary colorectal cancer collected after resection. Tissue was further extracted using laser-capture microdissection (LCM). No metastatic recurrence during follow-up.

colorectal cancer study 33 (carcinoma; cecum) / normal cecum tissue

Relative Expression (log2-ratio):-3.9868298
Number of Samples:4 / 2
Experimental colorectal cancer study 33 (carcinoma; cecum)
Primary tumor samples derived from the cecum of patients with carcinoma.
Control normal cecum tissue
Normal cecal tissue samples.

colorectal cancer study 9 (metastatic progression) / adjacent colon tissue (metastatic progression)

Relative Expression (log2-ratio):-3.9596033
Number of Samples:3 / 3
Experimental colorectal cancer study 9 (metastatic progression)
LCM-tumor tissue samples of patients who received resection after diagnosis of primary colorectal cancer with metastatic progression.
Control adjacent colon tissue (metastatic progression)
Histologically normal colon tissue samples from patients with primary colorectal cancer and metastatic progression collected after resection. Tissue was further extracted using laser-capture microdissection (LCM).

colorectal cancer study 33 (adenocarcinoma; cecum) / normal cecum tissue

Relative Expression (log2-ratio):-3.888341
Number of Samples:3 / 2
Experimental colorectal cancer study 33 (adenocarcinoma; cecum)
Primary tumor samples derived from the cecum of patients with adenocarcinoma.
Control normal cecum tissue
Normal cecal tissue samples.

colorectal cancer study 30 / normal colorectal tissue

Relative Expression (log2-ratio):-3.8641262
Number of Samples:45 / 4
Experimental colorectal cancer study 30
Formalin-fixed-paraffin-embedded (FFPE) colorectal tissue samples from patients with colorectal cancer.
Control normal colorectal tissue
Healthy, non-tumor colorectal tissue.